Nordson upgraded by Oppenheimer with a new price target
$NDSN
Industrial Machinery/Components
Industrials
Oppenheimer upgraded Nordson from Perform to Outperform and set a new price target of $260.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/18/2025 | Peer Perform | Wolfe Research | |
| 6/17/2025 | $245.00 | Hold | Vertical Research |
| 5/30/2025 | $260.00 | Perform → Outperform | Oppenheimer |
| 3/4/2025 | $260.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 2/24/2025 | $219.00 | Outperform → Neutral | Exane BNP Paribas |
| 1/22/2025 | $255.00 → $280.00 | Hold → Buy | Loop Capital |
| 12/17/2024 | $250.00 | Neutral → Buy | Seaport Research Partners |
| 12/13/2024 | $294.00 → $237.00 | Outperform → Neutral | Robert W. Baird |
Nordson Experts Foster Youth Readiness for Local Manufacturing/Engineering Careers Nordson EFD, a Nordson company (NASDAQ: NDSN), announced today it has completed two summer internships with Rhode Island high school students interested in manufacturing careers. The company partnered with Prepare RI, a strategic collaboration between the Rhode Island government, industry leaders, public education systems and non-profits across the state. In its ninth year, the initiative is designed to prepare Rhode Island youth for in-demand jobs and the workforce needed by state employers to thrive in the current and future economies. Nordson EFD has sponsored internships and students for decades in its
Nordson Corporation (NASDAQ:NDSN) has completed the divestiture of select product lines within its medical contract manufacturing business to Quasar Medical. "This divestiture allows Nordson MEDICAL to focus on its higher value growth opportunities within our $800 million medical and fluid solutions segment. This includes our growing portfolio of proprietary medical components, including balloons, cannula, nitinol devices and the recently acquired Atrion products," said Justin Hall, executive vice president, Nordson Medical and Fluid Solutions segment. "We are confident that our contract medical design and development business will thrive under Quasar's leadership, and we expect a smooth
This milestone enhances Quasar's global CDMO platform, broadening end-to-end capabilities and providing increased value for medical device OEMs and innovators. GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Quasar Medical, a global leader in manufacturing interventional and minimally invasive medical devices, today announced the completion of its acquisition of Nordson Corporation's (NASDAQ:NDSN) design & development contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico. Quasar's evolution into a fully integrated Contract Development and Manufacturing Organi
4 - NORDSON CORP (0000072331) (Issuer)
4 - NORDSON CORP (0000072331) (Issuer)
4 - NORDSON CORP (0000072331) (Issuer)
Wolfe Research initiated coverage of Nordson with a rating of Peer Perform
Vertical Research initiated coverage of Nordson with a rating of Hold and set a new price target of $245.00
Oppenheimer upgraded Nordson from Perform to Outperform and set a new price target of $260.00
10-Q - NORDSON CORP (0000072331) (Filer)
8-K - NORDSON CORP (0000072331) (Filer)
8-K - NORDSON CORP (0000072331) (Filer)
Nordson Corporation (NASDAQ:NDSN) today announced that its Board of Directors has approved a five percent increase in the Company's quarterly cash dividend to $0.82 per common share from $0.78. The dividend is payable on September 25, 2025, to shareholders of record as of the close of business on September 11, 2025. This increase represents Nordson's 62nd consecutive year of annual dividend increases, ranking it among an elite group of publicly traded companies with the longest-running record of consecutive dividend increases. "As a high quality industrial compounder, Nordson remains committed to returning value to our shareholders as part of our balanced capital deployment strategy," s
Third Quarter Highlights: Sales were $742 million, an increase of 12% year-over-year Earnings per diluted share were $2.22 Adjusted earnings per diluted share were $2.73, up 13% year-over-year Free cash flow conversion of 180% of net income Board of Directors approved a new $500 million share repurchase authorization Nordson Corporation (NASDAQ:NDSN) today reported results for the fiscal third quarter ended July 31, 2025. Sales were $742 million compared to the prior year's third quarter sales of $662 million. The third quarter 2025 sales included a favorable acquisition impact of 8%, an organic sales increase of 2% and a favorable currency translation impact of 2%.
Nordson Corporation (NASDAQ:NDSN) today announced that its board of directors declared a fiscal year 2025 third quarter cash dividend in the amount of $0.78 per common share, payable on July 3, 2025, to shareholders of record as of the close of business on June 19, 2025. This amount equals the $0.78 per common share dividend paid in the second quarter of fiscal year 2025. Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company's direct sales model and applications expertise serves global customers through a wi
SC 13G/A - NORDSON CORP (0000072331) (Subject)
SC 13G/A - NORDSON CORP (0000072331) (Subject)
SC 13G/A - NORDSON CORP (0000072331) (Subject)
Nordson Corporation (NASDAQ:NDSN) announced today that Justin Hall has been promoted to Executive Vice President (EVP) and Medical and Fluid Solutions (MFS) segment leader. Mr. Hall joined Nordson in 2006 and has a strong performance track record. He has held leadership positions within the Company's three segments and built deep expertise in deploying the NBS Next growth framework. Stephen Lovass, former EVP and MFS segment leader, will be leaving the Company, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428677805/en/Justin Hall "Justin is a tenured Nordson leader who has deployed NBS Next holisticall
RPM International Inc. (NYSE:RPM) today announced the appointment of three individuals, Craig S. Morford, Christopher L. Mapes and Julie A. Beck, to its board of directors. These appointments reflect RPM's ongoing commitment to expanding the expertise, diversity and leadership capabilities of its board as the company continues to drive long-term growth and shareholder value. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113146614/en/Christopher L. Mapes (Photo: Business Wire) The appointments of Mr. Morford and Mr. Mapes are effective immediately, and Ms. Beck's term is set to commence on April 7, 2025. With these additions,
Nordson Corporation (NASDAQ:NDSN) announced the election of Christopher L. Mapes, retired president and chief executive officer of Lincoln Electric Holdings, Inc. (NASDAQ:LECO), to its board of directors, effective today. Mr. Mapes has more than 38 years of experience leading diversified global manufacturing companies. Beyond his keen understanding of the manufacturing industry, Mr. Mapes has significant experience in the areas of mergers and acquisitions, global operations, international compliance and developing and implementing strategic operating plans. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240115539778/en/Christoph